179 related articles for article (PubMed ID: 28772110)
1. Leydig cell dysfunction, systemic inflammation and metabolic syndrome in long-term testicular cancer survivors.
Bandak M; Jørgensen N; Juul A; Lauritsen J; Oturai PS; Mortensen J; Hojman P; Helge JW; Daugaard G
Eur J Cancer; 2017 Oct; 84():9-17. PubMed ID: 28772110
[TBL] [Abstract][Full Text] [Related]
2. Quality of Life in Long-Term Testicular Cancer Survivors With Compensated Leydig Cell Dysfunction.
Skøtt JW; Lauritsen J; Kreiberg M; Daugaard G; Bandak M
Clin Genitourin Cancer; 2019 Feb; 17(1):e65-e71. PubMed ID: 30293923
[TBL] [Abstract][Full Text] [Related]
3. Reproductive hormones and metabolic syndrome in 24 testicular cancer survivors and their biological brothers.
Bandak M; Jørgensen N; Juul A; Lauritsen J; Kier MGG; Mortensen MS; Oturai PS; Mortensen J; Hojman P; Helge JW; Daugaard G
Andrology; 2017 Jul; 5(4):718-724. PubMed ID: 28598554
[TBL] [Abstract][Full Text] [Related]
4. Longitudinal Changes in Serum Levels of Testosterone and Luteinizing Hormone in Testicular Cancer Patients after Orchiectomy Alone or Bleomycin, Etoposide, and Cisplatin.
Bandak M; Jørgensen N; Juul A; Lauritsen J; Kier MGG; Mortensen MS; Daugaard G
Eur Urol Focus; 2018 Jul; 4(4):591-598. PubMed ID: 28753832
[TBL] [Abstract][Full Text] [Related]
5. A randomized double-blind study of testosterone replacement therapy or placebo in testicular cancer survivors with mild Leydig cell insufficiency (Einstein-intervention).
Bandak M; Jørgensen N; Juul A; Lauritsen J; Kreiberg M; Oturai PS; Helge JW; Daugaard G
BMC Cancer; 2017 Jul; 17(1):461. PubMed ID: 28673265
[TBL] [Abstract][Full Text] [Related]
6. A randomized double-blind single center study of testosterone replacement therapy or placebo in testicular cancer survivors with mild Leydig cell insufficiency (Einstein-intervention).
Kreiberg M; Jørgensen N; Juul A; Lauritsen J; Oturai P; Helge JW; Christensen JF; Aksglaede L; Schauer T; Wagner T; Rosenvilde J; Grunwald E; Dehlendorff C; Daugaard G; Bandak M
Clin Genitourin Cancer; 2022 Oct; 20(5):404-414. PubMed ID: 35701334
[TBL] [Abstract][Full Text] [Related]
7. Insulin-like factor 3, luteinizing hormone and testosterone in testicular cancer patients: effects of β-hCG and cancer treatment.
Steggink LC; van Beek AP; Boer H; Meijer C; Lubberts S; Oosting SF; de Jong IJ; van Ginkel RJ; Lefrandt JD; Gietema JA; Nuver J
Andrology; 2019 Jul; 7(4):441-448. PubMed ID: 30609309
[TBL] [Abstract][Full Text] [Related]
8. The metabolic syndrome and disturbances in hormone levels in long-term survivors of disseminated testicular cancer.
Nuver J; Smit AJ; Wolffenbuttel BH; Sluiter WJ; Hoekstra HJ; Sleijfer DT; Gietema JA
J Clin Oncol; 2005 Jun; 23(16):3718-25. PubMed ID: 15738540
[TBL] [Abstract][Full Text] [Related]
9. Quantification of the Leydig cell compartment in testicular biopsies and association with biochemical Leydig cell dysfunction in testicular cancer survivors.
Tarsitano MG; Bandak M; Jørgensen N; Skakkebaek NE; Juul A; Lenzi A; Daugaard G; Rajpert-De Meyts E
Andrology; 2018 Sep; 6(5):748-755. PubMed ID: 29981219
[TBL] [Abstract][Full Text] [Related]
10. Effect of Testosterone Replacement Therapy on Quality of Life and Sexual Function in Testicular Cancer Survivors With Mild Leydig Cell Insufficiency: Results From a Randomized Double-blind Trial.
Højer EG; Kreiberg M; Dehlendorff C; Jørgensen N; Juul A; Lauritsen J; Wagner T; Rosenvilde J; Daugaard G; Bandak M
Clin Genitourin Cancer; 2022 Aug; 20(4):334-343. PubMed ID: 35514022
[TBL] [Abstract][Full Text] [Related]
11. Hypogonadism in testicular cancer patients is associated with risk factors of cardiovascular disease and the metabolic syndrome.
Bogefors C; Isaksson S; Bobjer J; Kitlinski M; Leijonhufvud I; Link K; Giwercman A
Andrology; 2017 Jul; 5(4):711-717. PubMed ID: 28544654
[TBL] [Abstract][Full Text] [Related]
12. Metabolic Syndrome in Male Survivors of Pediatric Allogeneic Hematopoietic Stem Cell Transplantation: Impact of Total Body Irradiation, Low-Grade Inflammation, and Hypogonadism.
Muhic E; Mathiesen S; Nielsen MM; Suominen A; Sørensen K; Ifversen M; Nolsöe RL; Pedersen KM; Lähteenmäki P; Nordestgaard BG; Juul A; Jahnukainen K; Müller K
Transplant Cell Ther; 2021 Sep; 27(9):778.e1-778.e8. PubMed ID: 34091072
[TBL] [Abstract][Full Text] [Related]
13. Preorchiectomy Leydig Cell Dysfunction in Patients With Testicular Cancer.
Bandak M; Jørgensen N; Juul A; Lauritsen J; Gundgaard Kier MG; Mortensen MS; Daugaard G
Clin Genitourin Cancer; 2017 Feb; 15(1):e37-e43. PubMed ID: 27524512
[TBL] [Abstract][Full Text] [Related]
14. Testicular function after cytotoxic chemotherapy: evidence of Leydig cell insufficiency.
Howell SJ; Radford JA; Ryder WD; Shalet SM
J Clin Oncol; 1999 May; 17(5):1493-8. PubMed ID: 10334536
[TBL] [Abstract][Full Text] [Related]
15. Semen quality and reproductive hormones before orchiectomy in men with testicular cancer.
Petersen PM; Skakkebaek NE; Vistisen K; Rørth M; Giwercman A
J Clin Oncol; 1999 Mar; 17(3):941-7. PubMed ID: 10071288
[TBL] [Abstract][Full Text] [Related]
16. The impact of chemotherapy on Leydig cell function in long term survivors of germ cell tumors.
Gerl A; Mühlbayer D; Hansmann G; Mraz W; Hiddemann W
Cancer; 2001 Apr; 91(7):1297-303. PubMed ID: 11283930
[TBL] [Abstract][Full Text] [Related]
17. Single-nucleotide polymorphism in the 5-α-reductase gene (SRD5A2) is associated with increased prevalence of metabolic syndrome in chemotherapy-treated testicular cancer survivors.
Boer H; Westerink NL; Altena R; Nuver J; Dijck-Brouwer DAJ; van Faassen M; Klont F; Kema IP; Lefrandt JD; Zwart N; Boezen HM; Smit AJ; Meijer C; Gietema JA
Eur J Cancer; 2016 Feb; 54():104-111. PubMed ID: 26751392
[TBL] [Abstract][Full Text] [Related]
18. Genetic variations associated with the effect of testicular cancer treatment on gonadal hormones.
Aschim EL; Oldenburg J; Kristiansen W; Giwercman A; Witczak O; Fosså SD; Haugen TB
Hum Reprod; 2014 Dec; 29(12):2844-51. PubMed ID: 25336703
[TBL] [Abstract][Full Text] [Related]
19. Leydig cell micronodules are a common finding in testicular biopsies from men with impaired spermatogenesis and are associated with decreased testosterone/LH ratio.
Holm M; Rajpert-De Meyts E; Andersson AM; Skakkebaek NE
J Pathol; 2003 Mar; 199(3):378-86. PubMed ID: 12579540
[TBL] [Abstract][Full Text] [Related]
20. High prevalence of hypogonadism determined by serum free testosterone level in Japanese testicular cancer survivors.
Kurobe M; Kawai K; Suetomi T; Iwamoto T; Waku N; Kawahara T; Kojima T; Joraku A; Miyazaki J; Nishiyama H
Int J Urol; 2018 May; 25(5):457-462. PubMed ID: 29478250
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
